BERLIN (Reuters) -German pharmaceutical firm Stada is in talks with two private equity investors about a sale, Germany’s Welt newspaper reported on Tuesday.
Its owners Bain Capital and Cinven could seek an initial public offering in October if talks on a sale do not come to fruition, the report cited an unnamed source as saying.
A Stada spokesperson told Reuters the company was deliberating with its owners all options regarding the future ownership of the maker of generic drugs and consumer health products, including an IPO and a sale.
Reuters in March cited people familiar with the matter as saying that Stada postponed a planned IPO in Frankfurt because of market volatility.
Earlier on Tuesday, Stada said first-quarter operating earnings before special items rose a currency-adjusted 5% to 245 million euros ($279 million), driven by higher sales of specialty pharmaceuticals.
($1 = 0.8783 euros)
(Writing by Friederike HeineEditing by Ludwig Burger)
Comments